需住院COVID-19孕妇与非孕妇临床病程比较:英国多中心CA-COVID-19研究
该回顾性多中心观察研究比较了36例因COVID-19住院的孕妇与倾向性匹配的非孕妇队列。孕妇入院血红蛋白较低、淋巴细胞计数较高,其他血液学及生化指标无差异;非孕妇机械通气比例及入院24小时内接受低分子肝素血栓预防比例更高,两组住院时长、血栓发生率无显著差异,均无大出血或死亡。
要点
- 孕妇入院血红蛋白较低、淋巴细胞较高,其余血液学及生化指标与非孕妇无差异
- 非孕妇机械通气比例更高(31% vs 8%,P=0·03),住院24小时内LMWH血栓预防比例更高(69% vs 42%,P=0·03)
- 两组血栓发生率相似(各1例),均无大出血或死亡,血栓预防使用不一致提示需循证指导
核心结论
- 数据提示非孕妇临床病程更重,但孕妇与非孕妇总体结局无差异。
- 血栓预防使用不一致,提示需建立妊娠期COVID-19的循证指导。
研究设计与样本
- 回顾性多中心观察研究,36例因COVID-19住院孕妇与倾向性匹配的非孕妇队列比较。
主要发现
- 孕妇入院血红蛋白较低、淋巴细胞计数较高,其他血液学及生化指标无差异。
- 住院时长中位数孕妇2天(1-77),非孕妇8天(1-49),无显著差异。
- 非孕妇机械通气比例更高[11/36(31%)vs 3/36(8%),P=0·03]。
- 非孕妇入院24小时内接受LMWH血栓预防比例更高[25/36(69%)vs 15/36(42%),P=0·03]。
- 1例孕妇需ECMO;两组血栓发生率相似(各1例);无大出血或死亡。
关键数值与推荐
- 机械通气:非孕妇11/36(31%)vs 孕妇3/36(8%),P=0·03。
- 入院24小时内LMWH血栓预防:非孕妇25/36(69%)vs 孕妇15/36(42%),P=0·03。
- 住院时长中位数:孕妇2天(1-77),非孕妇8天(1-49)。
临床怎么用
- 妊娠期COVID-19住院患者应关注贫血与淋巴细胞变化,并评估血栓风险。
- 血栓预防使用不一致,临床决策需权衡妊娠期出血与血栓风险。
- 孕妇机械通气比例较低,但仍有重症(需ECMO)可能,需密切监测。
局限性
- 回顾性观察设计,样本量小(每组36例)。
- 血栓预防使用不一致,可能影响结局比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The impact of COVID-19 infection on pregnant women remains relatively unknown but the physiological changes of pregnancy and hypercoagulability of COVID-19 may further increase thrombotic risk. In this retrospective multicentre observational study, we report clinical characteristics and outcomes in 36 pregnant women requiring hospitalisation for COVID-19 compared to a propensity-matched cohort of non-pregnant women. Pregnant women had a lower haemoglobin and higher lymphocyte counts but no differences in other haematological or biochemical parameters on admission compared to non-pregnant women. There was no significant difference in the duration of hospitalisation; median two days (1-77) for pregnant versus eight days (1-49) for non-pregnant women. A higher proportion of non-pregnant women required mechanical ventilation [11/36 (31%) vs 3/36 (8%), P = 0·03] and received thromboprophylaxis with low-molecular-weight heparin (LMWH) within 24 h of admission [25/36 (69%) vs 15 /36(42%), P = 0·03] compared to pregnant women. One pregnant woman required extracorporeal membrane oxygenation. The rate of thrombosis was similar in both groups (one in each group). No women developed major bleeding or died. Data suggest that although non-pregnant women had a severe clinical course, overall outcomes were not different between women with or without pregnancy. The use of thromboprophylaxis was inconsistent, demonstrating a need for establishing evidence-based guidance for COVID-19 during pregnancy.
引用
- Crossette-Thambiah C, Nicolson P, Rajakaruna I, et al. The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study. Br J Haematol. 2021. PMID: 34132386. doi:10.1111/bjh.17579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。